ID: ALA176764

Max Phase: Preclinical

Molecular Formula: C10H22N2O2

Molecular Weight: 202.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC(=O)NCCCCCCCCN

Standard InChI:  InChI=1S/C10H22N2O2/c1-14-10(13)12-9-7-5-3-2-4-6-8-11/h2-9,11H2,1H3,(H,12,13)

Standard InChI Key:  SQIAUKSMMMXRPP-UHFFFAOYSA-N

Associated Targets(Human)

Polyamine oxidase 84 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 202.30Molecular Weight (Monoisotopic): 202.1681AlogP: 1.64#Rotatable Bonds: 8
Polar Surface Area: 64.35Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.21CX LogP: 1.37CX LogD: -1.23
Aromatic Rings: 0Heavy Atoms: 14QED Weighted: 0.59Np Likeness Score: -0.12

References

1. Dredar SA, Blankenship JW, Marchant PE, Manneh V, Fries DS..  (1989)  Design and synthesis of inhibitors of N8-acetylspermidine deacetylase.,  32  (5): [PMID:2709384] [10.1021/jm00125a010]

Source